Dolastatin 10 and dolastatin 15: Effects of two natural peptides on growth and differentiation of leukemia cells

Klaus G. Steube, Dörthe Grunicke, Torsten Pietsch, Suzanne M. Gignac, George Pettit, Hans G. Drexler

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Abstract

The effects of two natural peptides, dolastatin 10 and dolastatin 15, on growth and differentiation of hematopoietic cells were studied using freshly explanted leukemia cells and continuous leukemia cell lines. The proliferation of several myeloid cell lines and of growth-factor-stimulated peripheral blood cells from patients with acute myeloid leukemia (AML) was efficiently inhibited by the two agents at concentrations between 1 and 0.01 nM. Growth inhibition was dose-dependent and reversible. Neither of the dolastatins exhibited significant cytotoxicity on dividing cells, nor did they interfere with the viability of resting cells. The 12-O-tetradecanoylphorbol 13-acetate or bryostatin I induced differentiation of AML cells was not affected by the dolastatins. Short-term exposure to the phorbol ester conferred reduced sensitivity of the cell line HL-60 to the antiproliferative effect of the drugs. Our data suggest that the dolastatins alone or in combination with other drugs could exert a role in the treatment of human myeloid leukemia.

Original languageEnglish (US)
Pages (from-to)1048-1053
Number of pages6
JournalLeukemia
Volume6
Issue number10
StatePublished - Oct 1992

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Dolastatin 10 and dolastatin 15: Effects of two natural peptides on growth and differentiation of leukemia cells'. Together they form a unique fingerprint.

Cite this